毕得医药(688073.SH)股东拟合计减持不超3%股份

智通财经01-06

智通财经APP讯，毕得医药(688073.SH)发布公告，因股东自身流动性需求，股东欣曦管理、兰旦管理及其一致行动人吴波先生计划根据市场情况拟于本减持计划披露之日起15个交易日后的3个月内通过集中竞价、大宗交易方式减持其所持有的公司股份。其中，欣曦管理拟通过大宗交易方式减持公司股份数量不超过103.61万股，即不超过公司总股本的1.14%，通过集中竞价方式减持公司股份数量不超过36.35万股，即不...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2601895734?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-06 18:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601895734","market":"fut","top_or_hot":-1,"title":"毕得医药(688073.SH)股东拟合计减持不超3%股份","media":"智通财经","content":"<div>\n<p>智通财经APP讯，毕得医药(688073.SH)发布公告，因股东自身流动性需求，股东欣曦管理、兰旦管理及其一致行动人吴波先生计划根据市场情况拟于本减持计划披露之日起15个交易日后的3个月内通过集中竞价、大宗交易方式减持其所持有的公司股份。其中，欣曦管理拟通过大宗交易方式减持公司股份数量不超过103.61万股，即不超过公司总股本的1.14%，通过集中竞价方式减持公司股份数量不超过36.35万股，即不...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1389402.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>毕得医药(688073.SH)股东拟合计减持不超3%股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n毕得医药(688073.SH)股东拟合计减持不超3%股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-06 18:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1389402.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，毕得医药(688073.SH)发布公告，因股东自身流动性需求，股东欣曦管理、兰旦管理及其一致行动人吴波先生计划根据市场情况拟于本减持计划披露之日起15个交易日后的3个月内通过集中竞价、大宗交易方式减持其所持有的公司股份。其中，欣曦管理拟通过大宗交易方式减持公司股份数量不超过103.61万股，即不超过公司总股本的1.14%，通过集中竞价方式减持公司股份数量不超过36.35万股，即不...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1389402.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688073","symbol_name":"毕得医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1389402.html","article_id":"2601895734","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601895734","pubTimestamp":1767694786,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，毕得医药 发布公告，因股东自身流动性需求，股东欣曦管理、兰旦管理及其一致行动人吴波先生计划根据市场情况拟于本减持计划披露之日起15个交易日后的3个月内通过集中竞价、大宗交易方式减持其所持有的公司股份。减持价格将按照减持实际实施时的市场价格确定。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688073":"毕得医药","BK0216":"研究试验"},"translate_title":"Shareholders of Bide Pharmaceutical (688073. SH) plan to reduce their holdings by no more than 3% in total","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688073":1.5},"content_text":"智通财经APP讯，毕得医药(688073.SH)发布公告，因股东自身流动性需求，股东欣曦管理、兰旦管理及其一致行动人吴波先生计划根据市场情况拟于本减持计划披露之日起15个交易日后的3个月内通过集中竞价、大宗交易方式减持其所持有的公司股份。其中，欣曦管理拟通过大宗交易方式减持公司股份数量不超过103.61万股，即不超过公司总股本的1.14%，通过集中竞价方式减持公司股份数量不超过36.35万股，即不超过公司总股本的0.40%;兰旦管理拟通过大宗交易方式减持公司股份数量不超过78.16万股，即不超过公司总股本的0.86%，通过集中竞价方式减持公司股份数量不超过36.35万股，即不超过公司总股本的0.40%;股东吴波拟通过集中竞价交易方式减持公司股份数量不超过18.18万股，即不超过公司总股本的0.20%。减持价格将按照减持实际实施时的市场价格确定。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601895734","isCrawlerRequest":true}